HEMOTEQ
Live / Registered — Registered and renewed (as of 05 Feb 2025)
What this means for you
Registered since 08 Mar 2005. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Mar 2025).
Record
- Serial number
- 76326915
- Registration number
- 2931143
- Mark type
- Word mark
- Filed
- 18 Oct 2001
- Published for opposition
- 06 Apr 2004
- Registered
- 08 Mar 2005
- Next maintenance due
- 08 Mar 2025
- Attorney of record
- Gregory Turocy
Goods and services
- Class 005 — Pharmaceuticals: [ heparin preparations and heparin derivatives combined with organic macromolecular substances with anti-thrombotic and/or anti-coagulative properties for use in coating artificial and natural surfaces for intracorporeal and extracorporeal circulation and for use in coating surgical implants; surgical implants comprising living tissue and organs, namely, heats, heart parts, lungs, arteries, veins, aortas of mammals, especially hearts of pigs, heart valves of pigs and corpse veins; surgical implants comprising living tissue and organs coated with heparin, heparin derivatives and macromolecular agents, namely, hearts, heart valves, lungs, arteries, veins and aortas of mammals * all goods exclusive of the use of antibodies * ]
- Class 010 — Medical apparatus: [ surgical implants comprising artificial material, namely, artificial heart valves, hearts, lungs, arteries, veins and aortas; medical instruments and accessories for use with the transfer and handling of blood, namely, tubing, valves, containers, plastic bags, cans, needles, catheters and for use with artificial surgical implants for the cardiovascular system and for extracorporeal circulation; surgical implants comprising artificial material; anti-thrombotic and/or anti-coagulative surgical implants, artificial surfaces, namely, artificial surfaces, namely, artificial heart valves, artificial hearts, artificial lungs, artificial arteries, artificial veins, artificial aortas, tubing, valves, containers, plastic bags, cans, needles, catheters, and accessories for use with the transfer and handling of blood for medical purposes, especially for intracorporeal and extracorporeal circulation; artificial surgical implants coated with heparin, heparin derivatives and macromolecular agents, namely, artificial heart valves, hearts, lungs, arteries, veins and aortas; medical instruments and accessories for use with the transfer and handling of blood coated with heparin, heparin derivatives and macromolecular agents, namely, tubing, valves, containers, plastic bags, cans, needles, catheters and for use with artificial surgical implants for the cardiovascular system and for extracorporeal circulation * all goods exclusive of the use of antibodies * ]
- Class 040 — Treatment of materials: Commissioned coating services of artificial surgical implants and of surgical implants comprised of living tissue and organs with biopolymers, especially with heparin, heparin derivatives and anti-thrombotic and/or coagulative macromolecular substances * all coating services exclusive of the use of antibodies *
- Class 042 — Scientific and technological services: commissioned research and development services in the fields of surrogates for blood and blood substitutes, blood products, blood-compatible materials and blood-compatible implants; commissioned research and development and consultation services in the fields of artificial surgical implants and of surgical implants comprised of living tissue and organs for the cardiovascular system and for extracorporeal circulation, especially coatings with heparin, heparin derivatives and anti-thrombotic and/or anti-coagulative macromolecular substances; biochemical, pharmaceutical, medical and scientific research services in the fields of surrogates for blood, blood substitutes, blood products, blood-compatible material, blood-compatible implants and blood-compatible parts for the cardiovascular system and for extracorporeal circulation * all research and development services exclusive of the use of antibodies *
Owner
- HEMOTEQ AG, WUERSELEN, DE
- Hemoteq GmbH, 52146 Wurseten, DE
- Hemoteq GmbH, 52146 Wurseten, DE
- Hemoteq GmbH, 52146 Wurseten, DE
Prosecution history
- 05 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 Feb 2025 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 05 Feb 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Oct 2024 — TEAS SECTION 8 & 9 RECEIVED
- 08 Mar 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Dec 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Apr 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 25 Apr 2015 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 25 Apr 2015 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 23 Mar 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Mar 2015 — TEAS SECTION 8 & 9 RECEIVED
- 14 Jul 2011 — CANCELLATION TERMINATED NO. 999999
- 14 Jul 2011 — CANCELLATION DENIED NO. 999999
- 31 Mar 2011 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.